Arcadia Biosciences Cash Flow Statement (2014-2025) | RKDA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-5.33M	-5.42M	-2.85M	5.59M	-4.62M	-3.80M	-0.59M	-1.15M	-0.18M	-2.01M	-0.08M	-7.25M	-1.48M	-0.79M	-0.43M	-0.03M
Depreciation and Depletion (Quarter)	0.24M	0.25M	0.25M	0.19M	0.15M	0.13M	0.08M	0.09M	0.07M	0.03M	0.09M	-0.12M	0.05M	0.02M	0.01M	-0.03M	0.01M	0.01M	0.00M	0.00M
Share-based Compensation (Quarter)	0.33M	0.36M	0.35M	0.51M	0.26M	0.32M	0.31M	0.20M	0.21M	0.20M	0.16M	0.14M	0.14M	0.10M	0.15M	0.12M	0.08M	0.09M	0.05M	0.02M
Gains from Investment Securities (Quarter)	0.57M	0.98M			-0.02M	-0.04M	1.32M	-0.01M		0.08M	0.03M			0.06M	0.16M			0.21M	0.03M	3.07M
Asset Writedowns and Impairment (Quarter)	0.16M	0.82M	0.12M	2.28M	0.37M	1.10M	0.01M	2.47M	0.02M	0.17M	0.25M	-0.42M			0.15M
Non-cash Items (Quarter)	0.53M	0.61M	0.24M		161.25M	0.86M	0.87M			0.04M	0.04M			0.04M	0.05M	516.38M	0.03M	261.55M	0.13M
Cash from Operations (Quarter)	-4.71M	-6.23M	-8.27M	-6.66M	-4.88M	-3.37M	-3.37M	-2.38M	-3.47M	-4.80M	-2.88M	-4.15M	-3.21M	-2.46M	-1.75M	-2.18M	-1.59M	-2.01M	-0.30M	-0.84M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.29M	-0.24M	0.05M	0.02M	0.17M	-0.14M	0.66M	-0.65M	0.18M	0.18M	0.18M	0.16M	0.18M	0.17M	0.15M	0.15M	0.10M	0.01M	0.01M
Depreciation & Amortization (CF) (Quarter)	0.24M	0.25M	0.25M	0.19M	0.15M	0.13M	0.08M	0.09M	0.07M	0.03M	0.09M	-0.12M	0.05M	0.02M	0.01M	-0.03M	0.01M	0.01M	0.00M	0.00M
Change in Working Capital
Change in Receivables (Quarter)	0.29M	-0.55M	0.31M	-0.01M	1.40M	-0.07M	-0.80M	-1.13M	-0.08M	-0.01M	-0.16M	0.07M	0.25M	0.09M	0.11M	0.32M	0.19M	0.22M	-0.18M	-0.41M
Change in Inventory (Quarter)	-0.18M	0.82M	2.02M	-0.27M	-0.67M	-0.33M	-0.07M	-0.05M	0.04M	1.28M	0.07M	1.03M	-0.30M	-0.14M	-0.18M	0.07M	0.38M	0.20M	-0.03M	-0.24M
Change in Account Payables (Quarter)	-0.05M	0.01M	0.02M	0.01M	0.01M	0.01M	-0.04M	0.00M	-0.03M	0.02M	0.01M	0.01M	0.02M	0.01M	-0.05M			-0.03M
Change in Accured Expenses (Quarter)	0.00M	1.08M	-1.08M	-0.37M	-0.20M	0.21M	-0.90M	0.90M	-0.15M	0.16M	-0.31M	-0.22M	-0.68M	0.07M	0.60M	0.01M	-0.21M	0.16M
Other Working Capital Changes (Quarter)	0.09M	0.04M	0.21M	-0.51M	0.01M	0.04M	0.07M	0.63M		210.00	210.00	0.57M	-0.27M	0.01M	0.01M	0.80M	-0.12M	0.02M	0.02M	-0.64M
Investing Activities
Capital Expenditures (Quarter)	0.48M	0.23M	0.21M	0.09M	0.04M	0.01M		0.03M		0.01M			0.01M	0.00M
Sales of Property, Plant and Equipment (Quarter)				0.02M	0.79M	0.05M	0.01M	0.02M	0.03M	0.01M	0.01M	0.07M	0.02M	0.14M	0.18M	-0.01M
Change in Intangibles (Quarter)														4.00M		4.00M	0.50M	0.25M
Divestments (Quarter)							0.28M	0.28M	0.28M	0.28M
Change in Acquisitions & Divestments (Quarter)				0.00M								2.50M				2.52M
Cash from Investing Activities (Quarter)	-0.48M	17.37M	-0.20M	-0.07M	0.75M	0.05M	0.34M	0.28M	0.32M	-4.72M	0.01M	0.05M	0.00M	4.64M	0.18M	2.52M	0.50M	0.25M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	22.00M	-0.00M	0.02M	-0.11M	0.00M		4.51M		5.50M		0.01M		0.01M		0.00M		0.01M		0.00M
Additional items
Exchange Rate Effect (Quarter)				0.00M
Change in Cash (Quarter)	16.80M	11.13M	-8.45M	-6.84M	-4.13M	-3.32M	1.49M	-2.08M	2.35M	-9.51M	-2.87M	-4.09M	-3.20M	2.19M	-1.57M	0.31M	-1.08M	-1.78M	-0.26M	-0.86M
Free Cash Flow (Quarter)	-5.19M	-6.46M	-8.47M	-6.75M	-4.92M	-3.37M	-3.37M	-2.40M	-3.47M	-4.80M	-2.88M	-4.15M	-3.22M	-2.46M	-1.75M	-2.18M	-1.59M	-2.01M	-0.30M	-0.84M
Net Cash Flow (Quarter)	16.80M	11.13M	-8.45M	-6.84M	-4.13M	-3.32M	1.49M	-2.10M	2.35M	-9.51M	-2.87M	-4.10M	-3.20M	2.19M	-1.57M	0.33M	-1.08M	-1.76M	-0.30M	-0.84M

Research Tools

Arcadia Biosciences Cash Flow Statement (2014-2025) | RKDA

Create an account

Sign In

Reset Password